בטא
רדאר קליני AI
הניסוי הקליני NCT07490093 (QUALISENS) עבור Taste Alterations, הפרעת ריח, Eating Behavior Changes הוא טרם החל גיוס. לכל הפרטים, עיינו בתצוגת הכרטיסים של רדאר ניסויים קליניים ובכלי הגילוי של AI. אפשר גם לשאול כל דבר כאן.
מחקר אחד תואם לקריטריוני המסנן
תצוגת כרטיסים
חזרה לחיפוש

Adaptation Strategies for Coping With the Impact of Sensory Alterations on Eating Behavior in Children With Cancer: A Qualitative Study From the Perspective of Children and Parents (QUALISENS) 30 מהבית

טרם החל גיוס
פרטי הניסויים הקליניים זמינים בעיקר באנגלית. רדאר קליני AI יכול לעזור! לחץ על 'הסבר את המחקר' כדי לצפות ולשוחח על מידע מהמחקר בשפה המועדפת עליך.
הניסוי הקליני NCT07490093 (QUALISENS) הוא מחקר מסוג תצפיתי עבור Taste Alterations, הפרעת ריח, Eating Behavior Changes, שנמצא במצב טרם החל גיוס. גיוס המשתתפים צפוי להתחיל ב-1 בפברואר 2026, במטרה לכלול 30 משתתפים. המחקר ינוהל על ידי Centre Leon Berard וצפוי להסתיים ב-1 באוקטובר 2026. מידע זה עודכן לאחרונה באתר ClinicalTrials.gov ב-24 במרץ 2026.
סיכום קצר
Childhood cancer is a serious and life-changing disease that affects thousands of children every year worldwide. In addition to the disease itself, cancer treatments such as chemotherapy often cause difficult side effects. Among these, changes in taste and smell are very common but still poorly understood in children. These sensory changes can make food taste unpleasant or smell different, leading children to eat les...הצג עוד
תיאור מפורט
Childhood cancer represents a major public health concern and remains one of the leading causes of disease-related mortality in children. Advances in treatment have improved survival, but chemotherapy is frequently associated with adverse effects that significantly impact nutritional status and quality of life. Malnutrition affects approximately 40-60% of pediatric oncology patients and is associated with poorer trea...הצג עוד
כותרת רשמית

Adaptation Strategies for Coping With the Impact of Sensory Alterations on Eating Behavior in Children With Cancer: A Qualitative Study From the Perspective of Children and Parents

מצבים רפואיים
Taste Alterationsהפרעת ריחEating Behavior Changes
מזהי מחקר נוספים
  • QUALISENS
  • ET25-318
מספר NCT
NCT07490093
תחילת המחקר (בפועל)
2026-02
עדכון אחרון שפורסם
2026-03-24
סיום המחקר (מוערך)
2026-10
משתתפים (מתוכנן)
30
סוג המחקר
תצפיתי
סטטוס
טרם החל גיוס
מילות מפתח
chemotherapy
oncology
children
taste alterations
smell disorder
eating behaviour changes
coping strategies
זרועות / התערבויות
קבוצת משתתפים/זרועהתערבות/טיפול
children aged 6-17 years undergoing chemotherapy for a malignant hematological or solid tumor
No Intervention: Observational Cohort
no intervention
one of the parent of the children included in the first group
No Intervention: Observational Cohort
no intervention
מדדי תוצאה ראשיים
מדד תוצאהתיאור המדידהטווח זמן
coping strategies of the children and their parents for managment of sensory alterations and eating behaviour
Determine the coping strategies used by children and their parents to manage sensory alterations and eating behavior during chemotherapy. the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
מדדי תוצאה משניים
מדד תוצאהתיאור המדידהטווח זמן
Determine the effectiveness and purpose of these strategies.
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
Characterize the sensory alterations reported by children undergoing chemotherapy
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
Identify the frequency, reported intensity, and duration of alterations in taste, smell, and texture, and their role in eating behavior in children undergoing chemotherapy.
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
Determine the influence of cancer type and eating environment (hospital or home) on food perception
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
Study the impact of treatment type and stage on food perception and eating behavior.
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
Assess the role of sensory alterations on children's quality of life, particularly their emotional and social well-being.
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
Determine the relationship between the experiences of children and their parents by identifying their awareness of problems and their ability to describe them accurately.
the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
at least 2 months after the beginning of the chemotherapy
עוזר השתתפות
קריטריוני זכאות

גילאים מוערכים למחקר
ילד
גיל מינימלי למחקר
6 Years
מגדרים מוערכים למחקר
הכל

Children:

  • Aged 6 to 17 years old on the day consent is obtained.
  • Diagnosed with a malignant hematological or oncological tumor.
  • Possessing sufficient verbal ability to participate in the interview planned for the study.
  • Having started chemotherapy treatment at least 2 months prior.
  • Agreeing to participate in the study.
  • Able to understand, read, and write French.
  • Affiliated with a social security system.

Parents:

  • Be the parent or legal guardian of a child aged 6 to 17 inclusive, with cancer and undergoing chemotherapy.
  • Dated and signed informed consent.
  • Able to understand, read, and write French.

-
Centre Leon Berard logoCentre Leon Berard
Nutricia, Inc. logoNutricia, Inc.
איש קשר מרכזי למחקר
איש קשר: Samia Saraya, +33767889375, [email protected]
איש קשר: Séverine Bouttefroy, [email protected]
1 מיקומי המחקר ב-1 מדינות
Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, 69008, France